We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$301B
AUM Growth
+$28B
Cap. Flow
+$8.83B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.6%
Holding
3,648
New
163
Increased
2,481
Reduced
676
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 13.07%
3 Healthcare 12.05%
4 Consumer Discretionary 10.98%
5 Industrials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YARW
3326
Yarrow Bioscience, Inc. Common Stock
YARW
$20.3M
$71K ﹤0.01%
22
-88
-80% -$348K
FTK icon
3327
Flotek Industries
FTK
$789M
$69K ﹤0.01%
6,630
+3,873
+140% +$41.7K
SYBX
3328
DELISTED
Synlogic
SYBX
$68K ﹤0.01%
+1,161
New +$63.4K
TLPH icon
3329
Talphera
TLPH
$68M
$68K ﹤0.01%
2,428
-10,682
-81% -$286K
GNPX icon
3330
Genprex
GNPX
$3.6M
-2
Closed -$328K
XTIA icon
3331
XTI Aerospace
XTIA
$55.4M
0
EGY icon
3332
Vaalco Energy
EGY
$562M
$66K ﹤0.01%
20,055
JAGX icon
3333
Jaguar Health
JAGX
$4.74M
0
PHAS
3334
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$64K ﹤0.01%
17,190
-15,217
-47% -$50.6K
HEPA
3335
DELISTED
Hepion Pharmaceuticals
HEPA
$63K ﹤0.01%
32
IMNN icon
3336
Imunon
IMNN
$6.47M
$63K ﹤0.01%
251
+163
+185% +$38.5K
KRMD icon
3337
KORU Medical Systems
KRMD
$187M
$63K ﹤0.01%
13,520
-55,928
-81% -$220K
MITT
3338
TPG Mortgage Investment Trust
MITT
$228M
$62K ﹤0.01%
4,795
DMK
3339
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$62K ﹤0.01%
804
GNSS icon
3340
Genasys
GNSS
$76.5M
$61K ﹤0.01%
11,026
-70,921
-87% -$433K
GSIT icon
3341
GSI Technology
GSIT
$201M
$61K ﹤0.01%
10,802
-23,823
-69% -$147K
MTNB icon
3342
Matinas BioPharma
MTNB
$1.91M
$61K ﹤0.01%
1,568
WTER
3343
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$61K ﹤0.01%
+2,653
New +$48.5K
LQDA icon
3344
Liquidia Corp
LQDA
$7.72B
$60K ﹤0.01%
20,793
-38,132
-65% -$106K
SANW
3345
DELISTED
S&W Seed Co
SANW
$59K ﹤0.01%
842
CLIR icon
3346
ClearSign Technologies
CLIR
$25.4M
$58K ﹤0.01%
1,207
DHX icon
3347
DHI Group
DHX
$177M
$58K ﹤0.01%
17,016
-99,046
-85% -$314K
PHX
3348
DELISTED
PHX Minerals
PHX
$58K ﹤0.01%
+15,433
New +$46.9K
SRGA
3349
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$58K ﹤0.01%
1,379
-7,055
-84% -$361K
GYRE icon
3350
Gyre Therapeutics
GYRE
$629M
$57K ﹤0.01%
1,748
-8,751
-83% -$300K

Similar funds

Charles Schwab's Q2 2021 Portfolio in Review

As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
  • Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
  • Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
  • Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
  • Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
  • Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.